ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Application, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Research by Triton shows that the Asia-Pacific blood plasma market will be fast progressing at a CAGR of 6.38% in terms of revenue over the forecast period of 2019-2027.

The countries that have been studied in the Asia-Pacific blood plasma market are:

•           China

•           India

•           Japan

•           South Korea

•           ASEAN countries

•           Australia & New Zealand

•           Rest of Asia-Pacific

China has made major contributions to the growth of the blood plasma market in the Asia-Pacific region and the use of plasma in many therapeutic treatments is now widely accepted. In 2012, China accounted for 25 fractionation facilities, the highest number in the region. Japan has constructed only four plasma fractionation plants, while other countries such as Australia and India have only one each. China offers profitable opportunities ahead in the production of novel plasma therapies. Coagulation factors, intravenous immunoglobulin, albumin, normal immunoglobulins and other plasma products are already manufactured in the country.

The demand for intravenous immunoglobulins (IVIg) has increased in Australia, as they are reportedly used in over 70 clinical indications in addition to the treatment of idiopathic thrombocytopenic purpura (ITP), primary immune deficiency (PID), lymphoproliferative disorders (LPDs) and Kawasaki disease. Before 2005, plasma fractionation targeted the production of immunoglobulins and factor VIII, while a small proportion of total fractionated plasma was used in the manufacture of other products, such as albumin and other clotting factors. Regional market players such as CSL Bioplasma assisted in increasing the yield of intravenous immunoglobulins from 2000 to 2006. However, a shortage in this region persists due to limited accessibility to domestic plasma and the growing demand. Such factors are responsible for restraining the growth of the blood plasma market in Australia.

CSL Ltd. is an international company that specializes in manufacturing biotherapeutic products. The company manufactures and supplies innovative biotherapeutic products that offer safe treatments to people suffering from chronic medical conditions. CSL operates in over 30 countries and has a major geographical presence in Australia, Germany, Switzerland, the UK and the US. The company has achieved expertise in R&D, plasma products, vaccines and pharmaceuticals. CSL is an innovation-driven company that has a strong R&D foothold in new biotherapy development. The company focuses on R&D investments, as well as manufacturing of immunoglobulins, hemophilia products and breakthrough medicines. The company strives to develop innovative plasma therapies that improve patient care.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC BLOOD PLASMA MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES OUTLOOK

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF RIVALRY

2.3. VENDOR SCORECARD

2.4. CLINICAL GUIDELINES

2.5. REGULATION IN THE PLASMA THERAPEUTICS

2.6. KEY INSIGHTS

2.7. REGULATORY OUTLOOK

2.8. MARKET TRENDS

2.9. PATENT OUTLOOK

2.10.            MARKET DRIVERS

2.10.1.                EXPANSION IN INDICATION FOR NEW THERAPEUTIC AREAS

2.10.2.                APPROVAL OF IMMUNOGLOBULIN-CENTERED THERAPIES

2.10.3.                SURGE IN THE HEMOPHILIA TREATMENT

2.11.            MARKET RESTRAINTS

2.11.1.                HIGH COSTS OF BLOOD PLASMA TREATMENTS

2.11.2.                EASY AVAILABILITY OF RECOMBINANT PLASMA

2.12.            MARKET OPPORTUNITIES

2.12.1.                INCREASING PUBLIC COGNIZANCE

2.12.2.                RISE IN THE PLASMA-DERIVED PRODUCTS OPPORTUNITIES

2.12.3.                INCREASING OCCURRENCE OF HEMOPHILIA

2.13.            MARKET CHALLENGES

2.13.1.                SPREAD OF PATHOGENIC CONTAMINANTS

2.13.2.                HIGH REGULATIONS IN THE MARKET

2.14.            BLOOD PLASMA INDUSTRY BY MODE OF DELIVERY

2.14.1.                INFUSION SOLUTIONS

2.14.2.                GELS

2.14.3.                SPRAYS

2.14.4.                BIOMEDICAL SEALANTS

3.    BLOOD PLASMA MARKET OUTLOOK - BY BLOOD TYPE

3.1. ALBUMIN

3.2. IMMUNOGLOBULIN

3.2.1.   INTRAVENOUS IMMUNOGLOBULIN

3.2.2.   SUBCUTANEOUS IMMUNOGLOBULIN

3.2.3.   OTHER IMMUNOGLOBULIN TYPE

3.3. COAGULATION FACTOR CONCENTRATES

3.4. HYPERIMMUNE

3.5. OTHER PLASMA FRACTIONATION PRODUCTS

4.    BLOOD PLASMA MARKET OUTLOOK - BY APPLICATION

4.1. ONCOLOGY

4.2. HEMATOLOGY

4.3. TRANSPLANTATION

4.4. RHEUMATOLOGY

4.5. NEUROLOGY

4.6. IMMUNOLOGY

4.7. PULMONOLOGY

4.8. OTHER APPLICATIONS

5.    BLOOD PLASMA MARKET OUTLOOK - BY END-USER

5.1. ACADEMIC INSTITUTIONS

5.2. RESEARCH LABORATORIES

5.3. HOSPITALS AND CLINICS

6.    BLOOD PLASMA MARKET - REGIONAL OUTLOOK

6.1. ASIA-PACIFIC

6.1.1.   COUNTRY ANALYSIS

6.1.1.1.      JAPAN

6.1.1.2.      CHINA

6.1.1.3.      AUSTRALIA & NEW ZEALAND

6.1.1.4.      INDIA

6.1.1.5.      SOUTH KOREA

6.1.1.6.      ASEAN COUNTRIES

6.1.1.7.      REST OF ASIA-PACIFIC

7.    COMPANY PROFILES

7.1. SHIRE PLC

7.2. ARTHREX

7.3. OCTAPHARMA AG

7.4. BAXTER INTERNATIONAL, INC.

7.5. GRIFOLS INTERNATIONAL S.A.

7.6. BIOTEST AG

7.7. CSL LTD.

7.8. ADMA BIOLOGICS, INC.

7.9. CHINA BIOLOGIC PRODUCTS, INC.

7.10.            GENERAL ELECTRIC, CO.

7.11.            CERUS CORP.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

TABLE 2        BLOOD PLASMA COMPONENTS

TABLE 3        ASIA-PACIFIC BLOOD PLASMA MARKET BY BLOOD TYPE 2019-2027 ($ MILLION)

TABLE 4        ASIA-PACIFIC BLOOD PLASMA MARKET IN IMMUNOGLOBULIN BY TYPES 2019-2027 ($ MILLION)

TABLE 5        PROTEASE INHIBITORS USED IN THE HIV INFECTION TREATMENT

TABLE 6        ASIA-PACIFIC BLOOD PLASMA MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 6        ASIA-PACIFIC BLOOD PLASMA MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 7        ASIA-PACIFIC BLOOD PLASMA MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 2      IMMUNOGLOBULIN INFUSIONS SIDE-EFFECTS

FIGURE 3      ROLE OF FIBRIN SEALANT IN COAGULATION CASCADE

FIGURE 4      ASIA-PACIFIC BLOOD PLASMA MARKET IN ALBUMIN 2019-2027 ($ MILLION)

FIGURE 5      ASIA-PACIFIC BLOOD PLASMA MARKET IN IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 6      ASIA-PACIFIC IMMUNOGLOBULIN MARKET IN INTRAVENOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 7      ASIA-PACIFIC IMMUNOGLOBULIN MARKET IN SUBCUTANEOUS IMMUNOGLOBULIN 2019-2027 ($ MILLION)

FIGURE 8      ASIA-PACIFIC IMMUNOGLOBULIN MARKET IN OTHER IMMUNOGLOBULIN TYPE 2019-2027 ($ MILLION)

FIGURE 9      ASIA-PACIFIC BLOOD PLASMA MARKET IN COAGULATION FACTOR CONCENTRATES 2019-2027 ($ MILLION)

FIGURE 10   HYPERIMMUNES ISOLATION PROCESS

FIGURE 11   ASIA-PACIFIC BLOOD PLASMA MARKET IN HYPERIMMUNES 2019-2027 ($ MILLION)

FIGURE 12   ASIA-PACIFIC BLOOD PLASMA MARKET IN OTHER PLASMA FRACTIONATION PRODUCTS 2019-2027 ($ MILLION)

FIGURE 13   ASIA-PACIFIC BLOOD PLASMA MARKET IN ONCOLOGY 2019-2027 ($ MILLION)

FIGURE 14   ASIA-PACIFIC BLOOD PLASMA MARKET IN HEMATOLOGY 2019-2027 ($ MILLION)

FIGURE 15   ASIA-PACIFIC BLOOD PLASMA MARKET IN TRANSPLANTATION 2019-2027 ($ MILLION)

FIGURE 16   LUPUS INFECTION SYMPTOMS

FIGURE 17   ASIA-PACIFIC BLOOD PLASMA MARKET IN RHEUMATOLOGY 2019-2027 ($ MILLION)

FIGURE 18   ASIA-PACIFIC BLOOD PLASMA MARKET IN NEUROLOGY 2019-2027 ($ MILLION)

FIGURE 19   ASIA-PACIFIC BLOOD PLASMA MARKET IN PULMONOLOGY 2019-2027 ($ MILLION)

FIGURE 20   ASIA-PACIFIC BLOOD PLASMA MARKET IN IMMUNOLOGY 2019-2027 ($ MILLION)

FIGURE 21   ASIA-PACIFIC BLOOD PLASMA MARKET IN OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 22   ASIA-PACIFIC BLOOD PLASMA MARKET IN ACADEMIC INSTITUTIONS 2019-2027 ($ MILLION)

FIGURE 23   ASIA-PACIFIC BLOOD PLASMA MARKET IN RESEARCH LABORATORIES 2019-2027 ($ MILLION)

FIGURE 24   ASIA-PACIFIC BLOOD PLASMA MARKET IN HOSPITALS AND CLINICS 2019-2027 ($ MILLION)

FIGURE 25   JAPAN BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 26   CHINA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 27   AUSTRALIA & NEW ZEALAND BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 28   INDIA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 29   SOUTH KOREA BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 30   ASEAN COUNTRIES BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

FIGURE 31   REST OF ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;